Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavage

Elisabeth Möncke-Buchner1, Stefanie Reich, Merlind Mücke

  • 1Institute of Virology, Humboldt University Medical School (Charité), D-10098 Berlin, Germany.

Nucleic Acids Research
|August 15, 2002
PubMed

Insights

This study presents a new method to accurately count CAG repeat numbers in the Huntington's disease (HD) gene. This high-resolution assay aids in diagnosing HD and related genetic disorders.

Area of Science:

  • Genetics
  • Neurodegenerative Diseases
  • Molecular Biology

Background:

  • Huntington's disease (HD) is an autosomal-dominant neurodegenerative disorder.
  • It is caused by an expanded CAG trinucleotide repeat in the HD gene.
  • CAG repeat length varies significantly between affected and unaffected individuals.

Purpose of the Study:

  • To develop and validate a high-resolution method for determining CAG repeat numbers in the HD gene.
  • To accurately quantify CAG repeat expansions associated with Huntington's disease.

Main Methods:

  • DNA restriction using the endonuclease EcoP15I.
  • Analysis of restriction fragment patterns via non-denaturing polyacrylamide gel electrophoresis.
  • Utilizing the ALFexpress DNA Analysis System for precise fragment sizing.

Main Results:

  • The assay accurately determined CAG repeat numbers across normal (30-35 repeats) and pathological (81 repeats) ranges.
  • Demonstrated high-resolution capability for exact CAG repeat length determination.
  • Successfully applied the method to quantify CAG repeats in the HD gene.

Conclusions:

  • This high-resolution method provides accurate CAG repeat length determination for the HD gene.
  • The assay is suitable for diagnosing Huntington's disease.
  • This technique can be applied to study other CAG repeat expansion disorders.

Related Concept Videos